Literature DB >> 21901858

Lower airway microbiology and cellularity in children with newly diagnosed non-CF bronchiectasis.

Nitin Kapur1, Keith Grimwood, I Brent Masters, Peter S Morris, Anne B Chang.   

Abstract

BACKGROUND: Infection and inflammation are important in the pathogenesis of bronchiectasis. However, there are few published data describing the lower airway microbiology and cellularity in children.
METHODS: Children with non-cystic fibrosis (CF) bronchiectasis who underwent bronchoalveolar lavage (BAL) within 4 weeks of diagnosis were identified by a retrospective patient-record review. The effects of infection (≥10(5) colony-forming units of respiratory bacteria/ml; or detectable Pseudomonas aeruginosa; mycobacteria, fungi, mycoplasma, or respiratory viruses) on airway cellularity and the impact of age, gender, indigenous status, immune function, radiographic involvement and antibiotic usage on infection risk were evaluated.
RESULTS: Of 113 children [median age 63 months (IQR 32-95)] with newly diagnosed bronchiectasis, 77 (68%) had positive BAL cultures for respiratory bacterial pathogens. Haemophilus influenzae was most commonly detected, being present in 53 (47%) BAL specimens. P. aeruginosa was found in just 7 (6%) children, five of whom had an underlying disorder, while mycobacterial and fungal species were not detected. Respiratory viruses were identified in 14 (12%) children and Mycoplasma pneumoniae in two others. Overall, 56 (49.5%) children fulfilled our definition of a lower airway infection and of these, 35 (63%) had more than one pathogen present. Compared to children without infection, children with infection had higher total cell counts (610 vs. 280 × 10(6) /L), neutrophil counts (351 vs. 70 × 10(6) /L), and neutrophil percentages (69% vs. 34%). Age at diagnosis was most strongly associated with infection.
CONCLUSIONS: BAL microbiology of children with newly diagnosed bronchiectasis is dominated by H. influenzae. In the absence of CF, isolation of P. aeruginosa may suggest a serious co-morbidity in this group. Airway neutrophilia is common, especially with higher bacterial loads.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21901858     DOI: 10.1002/ppul.21550

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  34 in total

1.  Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation.

Authors:  K Venuprasad; Balamayooran Theivanthiran; Brandi Cantarel
Journal:  J Vis Exp       Date:  2016-03-02       Impact factor: 1.355

2.  Three clinically distinct chronic pediatric airway infections share a common core microbiota.

Authors:  Christopher J van der Gast; Leah Cuthbertson; Geraint B Rogers; Christopher Pope; Robyn L Marsh; Gregory J Redding; Kenneth D Bruce; Anne B Chang; Lucas R Hoffman
Journal:  Ann Am Thorac Soc       Date:  2014-09

3.  Paediatric chronic suppurative lung disease: clinical characteristics and outcomes.

Authors:  Vikas Goyal; Keith Grimwood; Julie M Marchant; I Brent Masters; Anne B Chang
Journal:  Eur J Pediatr       Date:  2016-06-11       Impact factor: 3.183

4.  Ataxia-telangiectasia mutated is required for the development of protective immune memory after influenza A virus infection.

Authors:  Rachel Warren; William Domm; Min Yee; Andrew Campbell; Jane Malone; Terry Wright; Margot Mayer-Pröschel; Michael A O'Reilly
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-09-11       Impact factor: 5.464

5.  Relationships Between Bronchoscopy, Microbiology, and Radiology in Noncystic Fibrosis Bronchiectasis.

Authors:  Mustafa Atilla Nursoy; Ayse Ayzit Kilinc; Fatouma Khalif Abdillahi; Feyza Ustabas Kahraman; Lina Muhammed Al Shadfan; Bilge Sumbul; Sabriye Sennur Bilgin; Fatma Betul Cakir; Hayrettin Daskaya; Erkan Cakir
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2021-05-14       Impact factor: 0.885

Review 6.  Dual antibiotics for bronchiectasis.

Authors:  Lambert M Felix; Seamus Grundy; Stephen J Milan; Ross Armstrong; Haley Harrison; Dave Lynes; Sally Spencer
Journal:  Cochrane Database Syst Rev       Date:  2018-06-11

Review 7.  The etiologies of non-CF bronchiectasis in childhood: a systematic review of 989 subjects.

Authors:  Kelly S Brower; Michael T Del Vecchio; Stephen C Aronoff
Journal:  BMC Pediatr       Date:  2014-12-10       Impact factor: 2.125

8.  Clinical and research priorities for children and young people with bronchiectasis: an international roadmap.

Authors:  Anne B Chang; Jeanette Boyd; Leanne Bell; Vikas Goyal; I Brent Masters; Zena Powell; Christine Wilson; Angela Zacharasiewicz; Efthymia Alexopoulou; Andrew Bush; James D Chalmers; Rebecca Fortescue; Adam T Hill; Bulent Karadag; Fabio Midulla; Gabrielle B McCallum; Deborah Snijders; Woo-Jung Song; Thomy Tonia; Keith Grimwood; Ahmad Kantar
Journal:  ERJ Open Res       Date:  2021-07-19

9.  Mycobacterium abscessus induces a limited pattern of neutrophil activation that promotes pathogen survival.

Authors:  Kenneth C Malcolm; E Michelle Nichols; Silvia M Caceres; Jennifer E Kret; Stacey L Martiniano; Scott D Sagel; Edward D Chan; Lindsay Caverly; George M Solomon; Paul Reynolds; Donna L Bratton; Jennifer L Taylor-Cousar; David P Nichols; Milene T Saavedra; Jerry A Nick
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

10.  Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial.

Authors:  Anne B Chang; Keith Grimwood; Andrew C Wilson; Peter P van Asperen; Catherine A Byrnes; Kerry-Ann F O'Grady; Theo P Sloots; Colin F Robertson; Paul J Torzillo; Gabrielle B McCallum; Ian B Masters; Helen M Buntain; Ian M Mackay; Jacobus Ungerer; Joanne Tuppin; Peter S Morris
Journal:  Trials       Date:  2013-02-20       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.